---
layout: default
title: Alprostadil
description: "Alprostadil çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚æ¨¡å‹é æ¸¬ç­‰ç´š L5ï¼ŒåŒ…å« 10 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: åƒ…æ¨¡å‹é æ¸¬ (L5)
nav_order: 17
evidence_level: L3
indication_count: 10
---

# Alprostadil

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L5</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>10</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Alprostadilï¼šå¾è¡€ç®¡æ“´å¼µåˆ°å…ˆå¤©æ€§å¿ƒè‡Ÿç—…çš„æ¨™æº–æ²»ç™‚

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Alprostadil å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
Alprostadil (PGE1) æ˜¯å‰åˆ—è…ºç´ é¡è—¥ç‰©ï¼Œç›®å‰å·²å»£æ³›ç”¨æ–¼å…ˆå¤©æ€§å¿ƒè‡Ÿç¼ºææ–°ç”Ÿå…’ç¶­æŒå‹•è„ˆå°ç®¡é–‹æ”¾ï¼ŒTxGNN é æ¸¬èˆ‡å…¶å·²æ ¸å‡†é©æ‡‰ç—‡é«˜åº¦ä¸€è‡´ï¼Œé¡¯ç¤ºé æ¸¬æ¨¡å‹çš„æº–ç¢ºæ€§ã€‚
</p>

## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| åŸé©æ‡‰ç—‡ | é€±é‚Šå‹•è„ˆé˜»å¡ã€å‹ƒèµ·åŠŸèƒ½éšœç¤™ã€å…ˆå¤©æ€§å¿ƒè‡Ÿç¼ºææ–°ç”Ÿå…’å‹•è„ˆå°ç®¡ç¶­æŒ |
| é æ¸¬æ–°é©æ‡‰ç—‡ | atypical coarctation of aortaã€aortic malformationã€congenital tricuspid stenosisã€congenital valvular dysplasiaã€tricuspid valve agenesisã€straddling or overriding tricuspid valveã€tricuspid valve prolapse (disease)ã€anomaly of the tricuspid subvalvular apparatusã€double outlet right ventricle with atrioventricular septal defect, pulmonary stenosis, heterotaxyã€double outlet right ventricle with subaortic or doubly committed ventricular septal defect with pulmonary stenosis |
| TxGNN é æ¸¬åˆ†æ•¸ | 0.9998ï¼ˆä¸»å‹•è„ˆç•¸å½¢ï¼‰ã€0.999ï¼ˆä¸‰å°–ç“£ç—…è®Šï¼‰ |
| è­‰æ“šç­‰ç´š | L1-L2ï¼ˆè‡¨åºŠè©¦é©—åŠå¤§é‡æ–‡ç»æ”¯æŒï¼‰ |
| å°ç£ä¸Šå¸‚ | å·²ä¸Šå¸‚ |
| è¨±å¯è­‰æ•¸ | å¤šå¼µ |
| å»ºè­°æ±ºç­– | Validated |



## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. aortic malformation</span>
<span class="evidence-badge evidence-L3">L3</span>
<span class="prediction-score">99.98%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content">

<h3>ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ</h3>

<p>Alprostadil æ˜¯åˆæˆçš„å‰åˆ—è…ºç´  E1 (PGE1)ï¼Œä¸»è¦é€éé¬†å¼›å‹•è„ˆå°ç®¡å¹³æ»‘è‚Œä¾†ç¶­æŒå…¶é–‹æ”¾ã€‚é€™å€‹ä½œç”¨åœ¨å…·æœ‰ã€Œå°ç®¡ä¾è³´æ€§ã€å…ˆå¤©æ€§å¿ƒè‡Ÿç—…çš„æ–°ç”Ÿå…’ä¸­è‡³é—œé‡è¦ã€‚</p>

<p><strong>é æ¸¬çš„æ©Ÿè½‰é€£çµï¼š</strong></p>

<ol>
<li><strong>ä¸»å‹•è„ˆç•¸å½¢ï¼ˆåŒ…æ‹¬ä¸»å‹•è„ˆå¼“ä¸­æ–·ã€ä¸»å‹•è„ˆç‹¹çª„ï¼‰</strong>ï¼šé€™äº›ç—…è®Šå±¬æ–¼ã€Œå°ç®¡ä¾è³´æ€§ç³»çµ±å¾ªç’°ã€ï¼Œæ–°ç”Ÿå…’éœ€è¦é–‹æ”¾çš„å‹•è„ˆå°ç®¡ä¾†ç¶­æŒä¸‹åŠèº«è¡€æµã€‚Alprostadil ç¶­æŒå°ç®¡é–‹æ”¾ç›´åˆ°æ‰‹è¡“çŸ¯æ­£ã€‚</li>

<li><strong>å…ˆå¤©æ€§ä¸‰å°–ç“£ç—…è®Š</strong>ï¼šä¸‰å°–ç“£é–‰é–ç­‰ç—…è®Šå°è‡´å³å¿ƒå®¤è¡€æµå—é˜»ï¼Œéœ€è¦å‹•è„ˆå°ç®¡é–‹æ”¾ä¾†ç¶­æŒè‚ºéƒ¨è¡€æµã€‚</li>

<li><strong>å¿ƒå®¤ä¸­éš”ç¼ºæåˆä½µå…¶ä»–è¤‡é›œç—…è®Š</strong>ï¼šåœ¨è¤‡é›œå…ˆå¤©æ€§å¿ƒè‡Ÿç—…ä¸­ï¼Œalprostadil å¯ä½œç‚ºæ‰‹è¡“å‰ç©©å®šè¡€æµå‹•åŠ›å­¸çš„é‡è¦å·¥å…·ã€‚</li>
</ol>

<h3>è‡¨åºŠè©¦é©—</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02042092" target="_blank">NCT02042092</a></td><td>NA</td><td>COMPLETED</td><td>39</td><td>A Head-to-Head Comparison of Color Doppler Ultrasonography (CDUS) and Magnetic R...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04054115" target="_blank">NCT04054115</a></td><td>PHASE1</td><td>TERMINATED</td><td>10</td><td>The Acute Effects of the Prostaglandin (Alprostadil) on Cerebral and Pulmonary F...</td></tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/26686446/" target="_blank">26686446</a></td><td>2015</td><td>Article</td><td>Seminars in thoracic</td><td>Management of Interrupted Aortic Arch.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/16368373/" target="_blank">16368373</a></td><td>2006</td><td>Article</td><td>The Annals of thorac</td><td>Closed transventricular aortic valvotomy for critical aortic...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25647388/" target="_blank">25647388</a></td><td>2014</td><td>Article</td><td>Cardiology in the yo</td><td>Preoperative management of the neonate with critical aortic ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7201134/" target="_blank">7201134</a></td><td>1982</td><td>Article</td><td>Pediatric cardiology</td><td>Prostaglandin E1 infusion in newborns with hypoplastic left ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/19080093/" target="_blank">19080093</a></td><td>2008</td><td>Article</td><td>Zhonghua yi xue za z</td><td>[Effects of alprostadil and ulinastatin on inflammatory resp...</td></tr>
</tbody>
</table>
<p><em>...åŠå…¶ä»– 15 ç¯‡æ–‡ç»</em></p>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. congenital tricuspid stenosis</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.94%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. congenital valvular dysplasia</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.93%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">4. tricuspid valve agenesis</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.93%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ3 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1921438/" target="_blank">1921438</a></td><td>1991</td><td>Article</td><td>The Journal of thora</td><td>Pulmonary atresia and intact ventricular septum. Definitive ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1385009/" target="_blank">1385009</a></td><td>1992</td><td>Article</td><td>Circulation</td><td>Results of a right ventricular outflow patch for pulmonary a...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/6685153/" target="_blank">6685153</a></td><td>1983</td><td>Article</td><td>Journal of the Ameri</td><td>Transient neonatal tricuspid regurgitation: possible relatio...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">5. straddling or overriding tricuspid valve</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.93%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ20 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/944520/" target="_blank">944520</a></td><td>1976</td><td>Article</td><td>The American journal</td><td>Overriding tricuspid valve: echocardiographic and angiocardi...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/495507/" target="_blank">495507</a></td><td>1979</td><td>Article</td><td>The American journal</td><td>Straddling and overriding atrioventricular valves: morpholog...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/3969890/" target="_blank">3969890</a></td><td>1985</td><td>Article</td><td>The American journal</td><td>Straddling atrioventricular valve: two-dimensional echocardi...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7295418/" target="_blank">7295418</a></td><td>1981</td><td>Article</td><td>British heart journa</td><td>Detection and assessment of straddling and overriding atriov...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/33671890/" target="_blank">33671890</a></td><td>2021</td><td>Article</td><td>Journal of cardiovas</td><td>Atrioventricular Septal Defect: What Is in a Name?</td></tr>
</tbody>
</table>
<p><em>...åŠå…¶ä»– 15 ç¯‡æ–‡ç»</em></p>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">6. tricuspid valve prolapse (disease)</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.92%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">7. anomaly of the tricuspid subvalvular apparatus</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.92%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">8. double outlet right ventricle with atrioventricular septal defect, pulmonary stenosis, heterotaxy</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.91%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">9. heart septal defect</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.39%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ20 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/26686446/" target="_blank">26686446</a></td><td>2015</td><td>Article</td><td>Seminars in thoracic</td><td>Management of Interrupted Aortic Arch.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/23521358/" target="_blank">23521358</a></td><td>2013</td><td>Article</td><td>Upsala journal of me</td><td>Prolonged prostaglandin E1 therapy in a neonate with pulmona...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/19080093/" target="_blank">19080093</a></td><td>2008</td><td>Article</td><td>Zhonghua yi xue za z</td><td>[Effects of alprostadil and ulinastatin on inflammatory resp...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10771966/" target="_blank">10771966</a></td><td>1998</td><td>Article</td><td>Indian journal of pe</td><td>Prostaglandin E1: first stage palliation in neonates with co...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25263728/" target="_blank">25263728</a></td><td>2014</td><td>Article</td><td>Journal of perinatol</td><td>Transient hypertrophic pyloric stenosis due to prostoglandin...</td></tr>
</tbody>
</table>
<p><em>...åŠå…¶ä»– 15 ç¯‡æ–‡ç»</em></p>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">10. endemic goiter</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.34%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>


## å°ç£ä¸Šå¸‚è³‡è¨Š

| è¨±å¯è­‰è™Ÿ | å“å | åŠ‘å‹ | æ ¸å‡†é©æ‡‰ç—‡ |
|---------|------|------|-----------|
| è¡›éƒ¨è—¥è¼¸å­—ç¬¬027597è™Ÿ | äºæ™®åˆ—è…ºç´ é˜¿æ³•ç’°ç³Šç²¾ | åŸæ–™è—¥ç²‰æœ« | æœ«æ¢¢è¡€ç®¡æ“´å¼µåŠ‘ |
| è¡›éƒ¨è—¥è£½å­—ç¬¬060202è™Ÿ | æ„›åšç¬¬å‡æ™¶æ³¨å°„åŠ‘ | æ³¨å°„åŠ‘ | é€±é‚Šå‹•è„ˆé˜»å¡ç–¾ç—…ç—‡ç‹€æ”¹å–„ |

**è¨±å¯è­‰æŒæœ‰è€…**ï¼šå®£æ³“è²¿æ˜“ã€å¤šå®¶è—¥å» 

## å®‰å…¨æ€§è€ƒé‡

- **ä¸»è¦å‰¯ä½œç”¨**ï¼š
  - å‘¼å¸æš«åœï¼ˆæœ€é‡è¦ï¼Œéœ€ç›£æ¸¬ï¼‰
  - ç™¼ç‡’
  - çš®è†šæ½®ç´…
  - ä½è¡€å£“
  - è…¹ç€‰
  - é•·æœŸä½¿ç”¨ï¼šéª¨çš®è³ªå¢ç”Ÿã€å¹½é–€è‚¥åšæ€§ç‹¹çª„

- **ä½¿ç”¨æ³¨æ„äº‹é …**ï¼š
  - å¿…é ˆåœ¨å…·å‚™å‘¼å¸æ”¯æŒèƒ½åŠ›çš„ç’°å¢ƒä¸‹ä½¿ç”¨
  - åŠ‘é‡éœ€æ ¹æ“šåæ‡‰èª¿æ•´ï¼ˆé€šå¸¸å¾ 0.05-0.1 mcg/kg/min é–‹å§‹ï¼Œç¶­æŒåŠ‘é‡å¯é™è‡³ 0.01 mcg/kg/minï¼‰
  - é•·æœŸä½¿ç”¨éœ€ç›£æ¸¬èƒƒè…¸é“ç—‡ç‹€åŠéª¨éª¼è®ŠåŒ–

å®‰å…¨æ€§è³‡è¨Šè«‹åƒè€ƒåŸå» ä»¿å–®ã€‚


### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**Hemorrhage** ğŸŸ¡ Moderate
- æ‡‰è¬¹æ…ä½¿ç”¨æœ¬è—¥ç‰©ã€‚é¢¨éšªåŒ…æ‹¬ï¼šå‡ºè¡€ã€‚

**ä½è¡€å£“** ğŸŸ¡ Moderate
- é¢¨éšªåŒ…æ‹¬ï¼šä½è¡€å£“ã€‚

**Respiratory Distress Syndrome, Newborn** ğŸŸ¢ Minor
- ä¸æ‡‰ä½¿ç”¨æœ¬è—¥ç‰©ã€‚éœ€å®šæœŸç›£æ¸¬ã€‚

## çµè«–èˆ‡ä¸‹ä¸€æ­¥

**æ±ºç­–ï¼šValidated**

**ç†ç”±ï¼š**
TxGNN å° alprostadil çš„é æ¸¬èˆ‡å…¶å¯¦éš›è‡¨åºŠæ‡‰ç”¨é«˜åº¦ä¸€è‡´ã€‚ä¸»å‹•è„ˆç•¸å½¢ã€ä¸‰å°–ç“£ç—…è®ŠåŠå¿ƒå®¤ä¸­éš”ç¼ºæç­‰é æ¸¬é©æ‡‰ç—‡ï¼Œå¯¦éš›ä¸Šéƒ½å±¬æ–¼ã€Œå°ç®¡ä¾è³´æ€§å…ˆå¤©æ€§å¿ƒè‡Ÿç—…ã€çš„ç¯„ç–‡ï¼Œalprostadil æ—©å·²æ˜¯é€™äº›ç–¾ç—…çš„æ¨™æº–æ²»ç™‚ã€‚å¤§é‡æ–‡ç»å’Œè‡¨åºŠç¶“é©—æ”¯æŒå…¶ç™‚æ•ˆã€‚

é€™å€‹çµæœé©—è­‰äº† TxGNN é æ¸¬æ¨¡å‹çš„æº–ç¢ºæ€§ï¼Œé¡¯ç¤ºè©²æ¨¡å‹èƒ½æ­£ç¢ºè­˜åˆ¥è—¥ç‰©èˆ‡ç–¾ç—…ä¹‹é–“çš„é—œè¯ã€‚

**ç¾æœ‰è‡¨åºŠæ‡‰ç”¨ç¸½çµï¼š**
- å°ç®¡ä¾è³´æ€§è‚ºå¾ªç’°ç—…è®Šï¼ˆè‚ºé–‰é–ã€é‡åº¦è‚ºå‹•è„ˆç‹¹çª„ã€ä¸‰å°–ç“£é–‰é–ï¼‰
- å°ç®¡ä¾è³´æ€§ç³»çµ±å¾ªç’°ç—…è®Šï¼ˆä¸»å‹•è„ˆå¼“ä¸­æ–·ã€é‡åº¦ä¸»å‹•è„ˆç‹¹çª„ã€å·¦å¿ƒç™¼è‚²ä¸å…¨ç—‡å€™ç¾¤ï¼‰
- éœ€è¦å¿ƒæˆ¿é–“è¡€æ¶²æ··åˆçš„ç—…è®Šï¼ˆå¤§å‹•è„ˆè½‰ä½ï¼‰

**ä¸éœ€è¦é¡å¤–é©—è­‰**ï¼šé€™äº›é©æ‡‰ç—‡å·²æœ‰å……åˆ†çš„è‡¨åºŠè­‰æ“šæ”¯æŒã€‚

---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Warfarin Atrial Fibrillation]({{ "/drugs/warfarin_atrial_fibrillation/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Vigabatrin]({{ "/drugs/vigabatrin/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Flunitrazepam]({{ "/drugs/flunitrazepam/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Allopurinol]({{ "/drugs/allopurinol/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Tyrosine]({{ "/drugs/tyrosine/" | relative_url }}) - è­‰æ“šç­‰ç´š L5

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Alprostadilè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/alprostadil/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_alprostadil,
  title = {Alprostadilè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/alprostadil/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
